REAL-TIME GLOBAL RESEARCH
Dana Inc: Buyback Resumption with Possibility of Continuation Post-Transaction; 2Q Results Mixed on EBITDA with FY Guide on EBITDA/FCF Raise; Expect +ve Reaction
Research evidence excerpt
J P M O R G A N
North America Equity Research
06 August 2026
Dana Inc
Buyback Resumption with Possibility of Continuation
Post-Transaction; 2Q Results Mixed on EBITDA with FY
Guide on EBITDA/FCF Raise; Expect +ve Reaction
Overweight
DAN, DAN US
Price (05 Aug 26):$28.02
Autos & Auto Parts
Quick take: A beat on sales though mixed on EBITDA (ahead of consensus, below
JPMe), with full year guidance raised due to CV trends, implying 2H revenue ~1%
ahead of JPMe/consensus and 2H EBITDA in line. 3Q26 also includes an expected
~$20 mn of one-time US union contract renewal costs, suggesting stronger core
performance vs. prior. Organic growth was +3% in the quarter vs. peer average of
+2% in 2Q26, with strong y/y margin expansion driven by performance and cost
savings as well as mix. Step-up in buyback near-term is a positive,
demonstrating commitment to capital return, with management suggesting
the possibility of continued buybacks post-close (vs. prior commentary of 2-yr
pause). Overall, in context of weakness in shares since the acquisition, and
shares at ~20% discount on EBITDA/FCF, the raise in guidance and
encouraging buyback outlook (incl. beyond acquisition) is likely to drive
outperformance today.
See Table 1 and Table 2 for results vs. JPMe/consensus and implied 2H
guidance.
)sre-tim
n
o
fd
ju
(a/C
M
P
.J
vlc2
A
6
Q
N
D
su
n
eo/C
M
P
.J
vcaid
G
6
0
2
H
lp
m
IN
A
D
Other Key Takeaways: Commercial Vehicle was the standout, with margin
expanding to 10.8% (from 7.8% in 2Q25) on +5% sales growth, while Light
Vehicle improved to 10.3% (from 8.4% in 2Q25). Cost savings of $19 mn in the
quarter took the YTD total to $54 mn vs. full year 2026 target of ~$65 mn. FCF
guidance was raised to ~$325 mn, and includes a 3Q26 one-time ~$20 mn signing
bonus tied to US union contract renewal. On the transaction, DAN reiterated at
least $250 mn of run-rate cost synergies within 24 months at ~$200 mn cash cost,
pro forma synergized 2026 net leverage of ~1.4x, and a 2030 sales target of $14-15
bn for the combined company. Growth initiatives included a VIPAR distribution
agreement worth ~$40 mn of additional aftermarket sales and ~$30 mn of new
defense sales in applied technologies.
…
The English excerpt is extracted automatically from the cited source page and may contain layout or recognition errors. It is never batch translated.
Open report viewer